Healthcare associated blood stream infections (BSI) pose a significant risk of morbidity and mortality for patients admitted to intensive care units (ICUs). Recent evidence suggests that the COVID-19 pandemic may have impacted the risk of acquisition.
Aim
This retrospective cohort study explored risk factors, including patient COVID-19 admission status, associated with incidence rates of BSI in Scottish ICUs during the COVID-19 pandemic compared to a pre-pandemic period.
Methods
Three national databases were linked to create a dataset of 38,081 ICU admissions across 41 ICUs during a comparator period of March 2018 to December 2019, and pandemic period of March 2020 to December 2021. Population demographics and clinical risk factors were described according to period of admission and COVID-19 admission status. Cox regression models investigated the influence of risk factors on time to BSI, using a competing risk approach to account for death as a competing event.
Findings
In non-COVID-19 patients, the first two waves of the pandemic significantly increased hazards of BSI (Wave 1 cause-specific hazard ratio (HR) 1.27, 95% Confidence Interval (CI) 1.02–1.59, wave 2a HR 1.39, 95% CI 1.14–1.70), but not mortality. COVID-19 status on admission did not significantly increase hazard of BSI in the pandemic, however there was a significant interaction between COVID-19 and the use of intubation in increasing hazard of BSI (HR 4.64, 95% CI 2.07–10.4) and COVID-19 was significant in increasing the hazard of mortality (HR 2.26, 95% CI 1.77–2.88).
Conclusion
While rates of ICU-acquired BSI were higher during the pandemic period, and in COVID-19 admissions, the reasons for this are multifactorial. Interpretation must consider the competing risk of mortality and how this is influenced by differences in patient population, along with changes that occurred during the pandemic in relation to infection prevention and control procedures, ICU pressures, and COVID-19 treatment and vaccination.
BonazzettiCMorenaVGiacomelliA, et al.Unexpectedly high frequency of enterococcal bloodstream infections in coronavirus disease 2019 patients admitted to an Italian ICU: An observational study. Crit Care Med. 2021;49(1):e31–e40. doi:10.1097/CCM.0000000000004748
4.
LepapeAMachutABretonniereC, et al.Effect of COVID-19 infection and pandemic period on healthcare-associated infections acquired in intensive care units. Clin Microbiol Infect.2023;29(4):530–536. doi:10.1016/j.cmi.2022.10.023
5.
ZhuNJRawsonTMMookerjeeS, et al.Changing patterns of bloodstream infections in the community and acute care across two COVID-19 epidemic waves: A retrospective analysis using data linkage. Clin Infect Dis. 2022;75(1):e1082–e1091. doi:10.1093/cid/ciab869
AustinPCLeeDSFineJP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133(6):601–609. doi:10.1161/CIRCULATIONAHA.115.017719
11.
R Core Team. R: A Language and Environment for Statistical Computing. R foundation for Statistical Computing; 2023.
BuettiNRucklySde MontmollinE, et al.COVID-19 increased the risk of ICU-acquired bloodstream infections: A case-cohort study from the multicentric OUTCOMEREA network. Intensive Care Med. 2021;47(2):180–187. doi:10.1007/s00134-021-06346-w
15.
PandeyMMayATanL, et al.Comparative incidence of early and late bloodstream and respiratory tract co-infection in patients admitted to ICU with COVID-19 pneumonia versus Influenza A or B pneumonia versus no viral pneumonia: Wales multicentre ICU cohort study. Crit Care. 2022;26(1):158. doi:10.1186/s13054-022-04026-9
16.
ÖnalUTüzemenÜKazakE, et al.Effects of COVID-19 pandemic on healthcare-associated infections, antibiotic resistance and consumption rates in intensive care units. Infez Med. 2023;31(2):195–203. doi:10.53854/liim-3102-7
17.
ARHAI Scotland. Impact of COVID-19 on surveillance programmes: October 2020. 2020. Internal Document.
18.
ARHAI Scotland. Impact of COVID-19 on surveillance programmes: April 2021. 2021. Internal Document.
HlinkovaSMoraucikovaELesnakovaAStrzeleckaALittvaV. Central line associated bloodstream infections in critical ill patients during and before the COVID-19 pandemic. Healthcare. 2023;11(17):2415. doi:10.3390/healthcare11172415
23.
FakihMGBufalinoASturmL, et al.Coronavirus disease 2019 (COVID-19) pandemic, central-line-associated bloodstream infection (CLABSI), and catheter-associated urinary tract infection (CAUTI): The urgent need to refocus on hardwiring prevention efforts. Infect Control Hosp Epidemiol. 2022;43(1):26–31. doi:10.1017/ice.2021.70
24.
Weiner-LastingerLMPattabiramanVKonnorRY, et al.The impact of coronavirus disease 2019 (COVID-19) on healthcare-associated infections in 2020: A summary of data reported to the national healthcare safety network. Infection Control & Hospital Epidemiology. 2022;43(1):12–25. doi:10.1017/ice.2021.362
25.
WeeLEIConceicaoEPTanJY, et al.Unintended consequences of infection prevention and control measures during COVID-19 pandemic. Am J Infect Control.2021;49(4):469–477. doi:10.1016/j.ajic.2020.10.019
SturdyABasarabMCotterM, et al.Severe COVID-19 and healthcare-associated infections on the ICU: Time to remember the basics?J Hosp Infect.2020;105(4):593–595. doi:10.1016/j.jhin.2020.06.027
BonazzettiCRinaldiMGiacomelliA, et al.Risk factors associated with bacteremia in COVID-19 patients admitted to intensive care unit: A retrospective multicenter cohort study. Infection. 2023;51(1):129–136. doi:10.1007/s15010-022-01853-4
31.
LinLLiuYTangXHeD. The disease severity and clinical outcomes of the SARS-CoV-2 variants of concern. Front Public Health. 2021 Nov 30;9:775224. doi:10.3389/fpubh.2021.775224
BerrySDNgoLSamelsonEJKielDP. Competing risk of death: An important consideration in studies of older adults. J Am Geriatr Soc. 2010;58(4):783–787. doi:10.1111/j.1532-5415.2010.02767.x
34.
Resche-RigonMAzoulayEChevretS. Evaluating mortality in intensive care units: Contribution of competing risks analyses. Crit Care. 2005;10(1):R5. doi:10.1186/cc3921
35.
AustinPCLeeDSFineJP. Introduction to the analysis of survival data in the presence of competing risks. Circulation. 2016;133(6):601–609. doi:10.1161/CIRCULATIONAHA.115.017719
OhkiRFukuiYMorishitaNIwataK. Increase of blood culture contamination during COVID-19 pandemic. A retrospective descriptive study. Am J Infect Control. 2021;49(11):1359–1361. doi:10.1016/j.ajic.2021.08.025.
38.
DamontiLKronenbergAMarschallJ, et al.Effect of the COVID-19 pandemic on the epidemiology of positive blood cultures in Swiss intensive care units: A nationwide surveillance study. Crit Care. 2021;25(1):403. doi:10.1186/s13054-021-03814-z
39.
TolleHNguyenAMacPhailA, et al.Increased incidence of blood culture contaminations during and after the COVID-19 pandemic. Infection. 2025;53:711–716. doi:10.1007/s15010-024-02469-6
40.
DriedgerMDanemanNBrownK, et al.The impact of the COVID-19 pandemic on blood culture practices and bloodstream infections. Microbiol Spectr.2023;11(6):e02630–23. doi:10.1128/spectrum.02630-23
41.
RamananMBurrellAPaulE, et al.Nosocomial infections among critically ill COVID-19 patients in Australia. J Clin Virol Plus. 2021;1(4):100054. doi:10.1016/j.jcvp.2021.100054
42.
GiacobbeDRBattagliniDBallL, et al.Bloodstream infections in critically ill patients with COVID-19. Eur J Clin Invest. 2020;50(10):e13319. doi:10.1111/eci.13319
43.
KurtAFMeteBUrkmezS, et al.Incidence, risk factors, and prognosis of bloodstream infections in COVID-19 patients in intensive care: A single-center observational study. J Intensive Care Med. 2022;37(10):1353–1362. doi:10.1177/08850666221103495
44.
StrelkovaDRachinaSFedinaL, et al.Identification of risk factors and development of a predictive model for bloodstream infection in intensive care unit COVID-19 patients. J Hosp Infect.2023 Sep;139:150–157. doi:10.1016/j.jhin.2023.06.026
45.
NIPCM. National Infection Prevention and Control Manual: Home. 2025. Accessed June 9, 2025. https://www.nipcm.scot.nhs.uk/.
VincentLIbrahimMKitchinJ, et al.Reduction in transfer of micro-organisms between patients and staff using short-sleeved gowns and hand/arm hygiene in intensive care during the COVID-19 pandemic: A simulation-based randomised trial. Journal of the Intensive Care Society. 2023;24(3):265–276. doi:10.1177/17511437221116472
52.
UlrichsTRollandMWuJNunesMCEl Guerche-SéblainCChitA. Changing epidemiology of COVID-19: Potential future impact on vaccines and vaccination strategies. Expert Rev Vaccines.2024;23(1):510–522. doi:10.1080/14760584.2024.2346589
53.
GuoYHanJZhangY, et al.SARS-CoV-2 omicron variant: Epidemiological features, biological characteristics, and clinical significance. Front Immunol. 2022 Apr 29;13:877101. doi:10.3389/fimmu.2022.877101
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
